HCA Healthcare, Inc. $HCA Holdings Trimmed by Strs Ohio

Strs Ohio decreased its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 3.9% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 86,727 shares of the company’s stock after selling 3,553 shares during the quarter. Strs Ohio’s holdings in HCA Healthcare were worth $40,489,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently bought and sold shares of the company. LVZ Inc. lifted its position in shares of HCA Healthcare by 8.1% in the fourth quarter. LVZ Inc. now owns 1,661 shares of the company’s stock worth $775,000 after purchasing an additional 124 shares in the last quarter. Sandro Wealth Management LLC purchased a new stake in HCA Healthcare in the 4th quarter worth approximately $3,100,000. Artemis Investment Management LLP grew its holdings in shares of HCA Healthcare by 18.3% during the 4th quarter. Artemis Investment Management LLP now owns 6,506 shares of the company’s stock valued at $3,037,000 after acquiring an additional 1,005 shares in the last quarter. Composition Wealth LLC raised its holdings in shares of HCA Healthcare by 3.0% during the fourth quarter. Composition Wealth LLC now owns 2,479 shares of the company’s stock worth $1,158,000 after acquiring an additional 72 shares in the last quarter. Finally, PFA Pension Forsikringsaktieselskab purchased a new position in HCA Healthcare in the fourth quarter valued at about $62,041,000. Hedge funds and other institutional investors own 62.73% of the company’s stock.

HCA Healthcare Price Performance

Shares of HCA Healthcare stock opened at $433.73 on Friday. The firm has a fifty day moving average price of $497.66 and a two-hundred day moving average price of $485.93. HCA Healthcare, Inc. has a fifty-two week low of $330.00 and a fifty-two week high of $556.52. The company has a market cap of $96.50 billion, a PE ratio of 14.92, a price-to-earnings-growth ratio of 1.37 and a beta of 1.19.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Friday, April 24th. The company reported $7.15 EPS for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). The company had revenue of $19.11 billion for the quarter, compared to analyst estimates of $19.09 billion. HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The firm’s quarterly revenue was up 4.3% on a year-over-year basis. During the same period in the prior year, the company posted $6.45 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Analysts expect that HCA Healthcare, Inc. will post 30.05 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 30th. Investors of record on Tuesday, June 16th will be paid a $0.78 dividend. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date is Tuesday, June 16th. HCA Healthcare’s dividend payout ratio is presently 10.73%.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, EVP Michael S. Cuffe sold 1,500 shares of the business’s stock in a transaction on Tuesday, February 3rd. The shares were sold at an average price of $498.09, for a total value of $747,135.00. Following the sale, the executive vice president owned 30,003 shares of the company’s stock, valued at $14,944,194.27. The trade was a 4.76% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, EVP Michael R. Mcalevey sold 1,694 shares of HCA Healthcare stock in a transaction dated Wednesday, February 18th. The shares were sold at an average price of $533.37, for a total transaction of $903,528.78. Following the sale, the executive vice president owned 8,853 shares in the company, valued at approximately $4,721,924.61. This trade represents a 16.06% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 15,214 shares of company stock worth $7,797,595 over the last three months. 1.50% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

Several brokerages have recently issued reports on HCA. TD Cowen reduced their price target on HCA Healthcare from $561.00 to $500.00 and set a “buy” rating for the company in a report on Monday, April 27th. Cantor Fitzgerald reissued an “overweight” rating on shares of HCA Healthcare in a research report on Wednesday, March 4th. Wells Fargo & Company reduced their price objective on shares of HCA Healthcare from $481.00 to $436.00 and set an “equal weight” rating for the company in a research note on Monday, April 27th. Argus increased their target price on shares of HCA Healthcare from $530.00 to $560.00 and gave the stock a “buy” rating in a research report on Friday, February 6th. Finally, Barclays decreased their price target on HCA Healthcare from $551.00 to $496.00 and set an “overweight” rating for the company in a research note on Monday, April 27th. Sixteen analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, HCA Healthcare has a consensus rating of “Moderate Buy” and an average price target of $520.55.

About HCA Healthcare

HCA Healthcare is a for?profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.